Investigation of Microemulsion System for Transdermal Drug Delivery of Amphotericin B

被引:0
作者
Tian Qing-ping [1 ,2 ]
Li Peng [2 ]
Xie Ke-chang [1 ]
机构
[1] Taiyuan Univ Technol, Minist Educ & Shanxi Prov, Key Lab Coal Sci & Technol, Taiyuan 030024, Peoples R China
[2] Shanxi Med Univ, Dept Pharm, Taiyuan 030001, Peoples R China
关键词
Microemulsion; Transdermal drug delivery; Amphotericin B; pH; FORMULATION;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In order to solve the drawback of poor bioavailability by the oral route and infusion-related side effect for Amphotericin B(AmB), microemulsion vehicles composed of isopropyl myristate(IPM), Tween 80, isopropyl alcohol and water for transdermal delivery of AmB were designed. The pseudo-ternary phase diagrams were constructed by the H2O titration method and the structures of the microemulsion were determined by measuring electrical conductivities(sigma). The diffusion studies of AmB microemulsion were performed via excised rabbit skin on a drug diffusion apparatus. To obtain a high solubization of AmB, three different methods were tested to incorporate AmB into microemulsion. The result suggests adding AmB in the shape of NaOH solution to the O/W blank microemulsion over the phase inversion temperature(PIT) of the emulsifier obtains the maximum drug content(2.96 mg/mL). The pH value of the system could be adjusted to pH>8.5 or pH<5.2, in this range AmB molecules converts from aqueous to the hydrophilic shell of the microemulsion droplets, drug precipitate is no more than 5%, and the formulations were corresponding to the characterizations of microemulsion. At pH 5.14, AmB microemulsion with K-m 1:1, O/SC 1:9(mass ratio of oil phase to surfactant/cosurfactant blend), water content 64.6%, drug content (2.93 +/- 0.08) mg/mL, showed the maximum permeation rate (3.255 +/- 0.64) mu g.cm(-2).h(-1), which is stable for a long time.
引用
收藏
页码:86 / 94
页数:9
相关论文
共 18 条
[1]  
Adler-Moore P.J., 1993, J LIPOSOME RES, V3, P429
[2]  
Bennett K. E., 1982, Microemulsions. Proceedings of a Conference on the Physical Chemistry of Microemulsions, P65
[3]   Amphotericin B in oil-water lecithin-based microemulsions: Formulation and toxicity evaluation [J].
Brime, B ;
Moreno, MA ;
Frutos, G ;
Ballesteros, MP ;
Frutos, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (04) :1178-1185
[4]   A study of microemulsion systems for transdermal delivery of triptolide [J].
Chen, HB ;
Chang, XL ;
Weng, T ;
Zhao, XZ ;
Gao, ZH ;
Yang, YJ ;
Xu, HB ;
Yang, XL .
JOURNAL OF CONTROLLED RELEASE, 2004, 98 (03) :427-436
[5]   Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug [J].
Djordjevic, L ;
Primorac, M ;
Stupar, M ;
Krajisnik, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 271 (1-2) :11-19
[6]   Amphiphilic association systems for Amphotericin B delivery [J].
Esposito, E ;
Bortolotti, F ;
Menegatti, E ;
Cortesi, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 260 (02) :249-260
[7]  
Gasco MR., 1997, IND APPL MICROEMULSI, P97
[8]  
Guo S.L., 1993, J LIPOSOME RES, V3, P473
[9]  
Janoff A.S., 1993, J LIPOSOME RES, V3, P451
[10]   NMR characterisation and transdermal drug delivery potential of microemulsion systems [J].
Kreilgaard, M ;
Pedersen, EJ ;
Jaroszewski, JW .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (03) :421-433